CytoSorbents Corporation (CTSO)

[cougfan531]

CytoSorbents PT Raised to $1.00 at Brean Capital (CTSO)

Posted by Stuart Ham on Apr 1st, 2014 // No Comments



Equities research analysts at Brean Capital hoisted their price target on shares of CytoSorbents (NASDAQ:CTSO) to $1.00 in a research note issued to investors on Tuesday, Analyst Ratings.Net reports. Brean Capital’s target price suggests a potential upside of 334.78% from the stock’s previous close.

Shares of CytoSorbents (NASDAQ:CTSO) opened at 0.23 on Tuesday. CytoSorbents has a one year low of $0.08 and a one year high of $0.35. The stock’s 50-day moving average is $0.24 and its 200-day moving average is $0.16. The company’s market cap is $56.8 million.

CytoSorbents (NASDAQ:CTSO) last posted its quarterly earnings results on Monday, March 31st. The company reported ($0.01) earnings per share for the quarter, meeting the analysts’ consensus estimate of ($0.01). Analysts expect that CytoSorbents will post $-0.03 EPS for the current fiscal year.

Separately, analysts at Zacks reiterated an “outperform” rating on shares of CytoSorbents in a research note on Friday, January 17th. They now have a $0.50 price target on the stock.

CytoSorbents Corporation, formerly MedaSorb Technologies Corporation, is a development-stage therapeutic medical device company.


Too bad we're not actually on the NASDAQ yet.